1 Market Overview
    1.1 Peptide Manufacturing and Development Services Definition
    1.2 Global Peptide Manufacturing and Development Services Market Size and Forecast
    1.3 China Peptide Manufacturing and Development Services Market Size and Forecast
    1.4 Share of China Peptide Manufacturing and Development Services Market with Respect to the Global Market
    1.5 Peptide Manufacturing and Development Services Market Size: China VS Global Growth Rate, 2020-2031
    1.6 Peptide Manufacturing and Development Services Market Dynamics
        1.6.1 Peptide Manufacturing and Development Services Market Drivers
        1.6.2 Peptide Manufacturing and Development Services Market Restraints
        1.6.3 Peptide Manufacturing and Development Services Industry Trends
        1.6.4 Peptide Manufacturing and Development Services Industry Policy
2 Global Leading Players and Market Share
    2.1 By Revenue of Peptide Manufacturing and Development Services, Global Market Share by Company, 2020-2025
    2.2 Global Peptide Manufacturing and Development Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Peptide Manufacturing and Development Services Concentration Ratio
    2.4 Global Peptide Manufacturing and Development Services Mergers & Acquisitions, Expansion Plans
    2.5 Global Peptide Manufacturing and Development Services Major Companies Product Type
    2.6 Head Office and Area Served of Key Players
3 China Leading Players, Market Share and Ranking
    3.1 By Revenue of Peptide Manufacturing and Development Services, China Market Share by Company, 2020-2025
    3.2 China Peptide Manufacturing and Development Services Peptide Manufacturing and Development Services Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
    4.1 Peptide Manufacturing and Development Services Industry Chain
    4.2 Peptide Manufacturing and Development Services Upstream Analysis
        4.2.1 Peptide Manufacturing and Development Services Core Raw Materials
        4.2.2 Main Manufacturers of Peptide Manufacturing and Development Services Core Raw Materials
    4.3 Midstream Analysis
    4.4 Downstream Analysis
    4.5 Peptide Manufacturing and Development Services Production Mode
    4.6 Peptide Manufacturing and Development Services Procurement Model
    4.7 Peptide Manufacturing and Development Services Industry Sales Model and Sales Channels
        4.7.1 Peptide Manufacturing and Development Services Sales Model
        4.7.2 Peptide Manufacturing and Development Services Typical Distributors
5 Sights by Type
    5.1 Peptide Manufacturing and Development Services Classification by Type
        5.1.1 GMP Services
        5.1.2 Non-GMP Services
    5.2 by Type, Global Peptide Manufacturing and Development Services Consumption Value & CAGR, 2020 VS 2024 VS 2031
    5.3 by Type, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
6 Sights by Synthesis Technology
    6.1 Peptide Manufacturing and Development Services Classification by Synthesis Technology
        6.1.1 SPPS
        6.1.2 LPPS
        6.1.3 Hybrid Technology
    6.2 by Synthesis Technology, Global Peptide Manufacturing and Development Services Consumption Value & CAGR, 2020 VS 2024 VS 2031
    6.3 by Synthesis Technology, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
7 Sights by Customer
    7.1 Peptide Manufacturing and Development Services Classification by Customer
        7.1.1 Pharma Companies
        7.1.2 Biotech Firms
        7.1.3 Academic & Research
        7.1.4 Others
    7.2 by Customer, Global Peptide Manufacturing and Development Services Consumption Value & CAGR, 2020 VS 2024 VS 2031
    7.3 by Customer, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
8 Sights by Form
    8.1 Peptide Manufacturing and Development Services Classification by Form
        8.1.1 Peptide APIs
        8.1.2 Intermediates
        8.1.3 Modified & Conjugated Peptides
        8.1.4 Others
    8.2 by Form, Global Peptide Manufacturing and Development Services Consumption Value & CAGR, 2020 VS 2024 VS 2031
    8.3 by Form, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
9 Sights by Application
    9.1 Peptide Manufacturing and Development Services Segment by Application
        9.1.1 Pharmaceutical & Biotechnology
        9.1.2 Diagnostics & IVD
        9.1.3 Aesthetics & Dermatology
        9.1.4 Others
    9.2 by Application, Global Peptide Manufacturing and Development Services Consumption Value & CAGR, 2020 VS 2024 VS 2031
    9.3 by Application, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
10 Sales Sights by Region
    10.1 By Region, Global Peptide Manufacturing and Development Services Consumption Value, 2020 VS 2024 VS 2031
    10.2 By Region, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
    10.3 North America
        10.3.1 North America Peptide Manufacturing and Development Services Market Size & Forecasts, 2020-2031
        10.3.2 By Country, North America Peptide Manufacturing and Development Services Market Size Market Share
    10.4 Europe
        10.4.1 Europe Peptide Manufacturing and Development Services Market Size & Forecasts, 2020-2031
        10.4.2 By Country, Europe Peptide Manufacturing and Development Services Market Size Market Share
    10.5 Asia Pacific
        10.5.1 Asia Pacific Peptide Manufacturing and Development Services Market Size & Forecasts, 2020-2031
        10.5.2 By Country/Region, Asia Pacific Peptide Manufacturing and Development Services Market Size Market Share
    10.6 South America
        10.6.1 South AmericaPeptide Manufacturing and Development Services Market Size & Forecasts, 2020-2031
        10.6.2 By Country, South America Peptide Manufacturing and Development Services Market Size Market Share
    10.7 Middle East & Africa
11 Sales Sights by Country Level
    11.1 By Country, Global Peptide Manufacturing and Development Services Market Size & CAGR, 2020 VS 2024 VS 2031
    11.2 By Country, Global Peptide Manufacturing and Development Services Consumption Value, 2020-2031
    11.3 United States
        11.3.1 United States Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.3.2 by Type, United States Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.3.3 by Application, United States Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.4 Europe
        11.4.1 Europe Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.4.2 by Type, Europe Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.4.3 by Application, Europe Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.5 China
        11.5.1 China Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.5.2 by Type, China Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.5.3 by Application, China Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.6 Japan
        11.6.1 Japan Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.6.2 by Type, Japan Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.6.3 by Application, Japan Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.7 South Korea
        11.7.1 South Korea Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.7.2 by Type, South Korea Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.7.3 by Application, South Korea Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.8 Southeast Asia
        11.8.1 Southeast Asia Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.8.2 by Type, Southeast Asia Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.8.3 by Application, Southeast Asia Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.9 India
        11.9.1 India Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.9.2 by Type, India Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.9.3 by Application, India Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
    11.10 Middle East & Africa
        11.10.1 Middle East & Africa Peptide Manufacturing and Development Services Market Size, 2020-2031
        11.10.2 by Type, Middle East & Africa Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
        11.10.3 by Application, Middle East & Africa Peptide Manufacturing and Development Services Consumption Value Market Share, 2024 VS 2031
12 Company Profile
    12.1 PolyPeptide
        12.1.1 PolyPeptide Company Information, Head Office, Market Area, and Industry Position
        12.1.2 PolyPeptide Company Profile and Main Business
        12.1.3 PolyPeptide Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.1.4 PolyPeptide Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.1.5 PolyPeptide Recent Developments
    12.2 Bachem
        12.2.1 Bachem Company Information, Head Office, Market Area, and Industry Position
        12.2.2 Bachem Company Profile and Main Business
        12.2.3 Bachem Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.2.4 Bachem Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.2.5 Bachem Recent Developments
    12.3 AmbioPharm
        12.3.1 AmbioPharm Company Information, Head Office, Market Area, and Industry Position
        12.3.2 AmbioPharm Company Profile and Main Business
        12.3.3 AmbioPharm Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.3.4 AmbioPharm Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.3.5 AmbioPharm Recent Developments
    12.4 CordenPharma
        12.4.1 CordenPharma Company Information, Head Office, Market Area, and Industry Position
        12.4.2 CordenPharma Company Profile and Main Business
        12.4.3 CordenPharma Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.4.4 CordenPharma Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.4.5 CordenPharma Recent Developments
    12.5 CPC Scientific
        12.5.1 CPC Scientific Company Information, Head Office, Market Area, and Industry Position
        12.5.2 CPC Scientific Company Profile and Main Business
        12.5.3 CPC Scientific Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.5.4 CPC Scientific Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.5.5 CPC Scientific Recent Developments
    12.6 Piramal Pharma Solutions
        12.6.1 Piramal Pharma Solutions Company Information, Head Office, Market Area, and Industry Position
        12.6.2 Piramal Pharma Solutions Company Profile and Main Business
        12.6.3 Piramal Pharma Solutions Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.6.4 Piramal Pharma Solutions Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.6.5 Piramal Pharma Solutions Recent Developments
    12.7 Almac Group
        12.7.1 Almac Group Company Information, Head Office, Market Area, and Industry Position
        12.7.2 Almac Group Company Profile and Main Business
        12.7.3 Almac Group Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.7.4 Almac Group Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.7.5 Almac Group Recent Developments
    12.8 Vtides Life Sciences
        12.8.1 Vtides Life Sciences Company Information, Head Office, Market Area, and Industry Position
        12.8.2 Vtides Life Sciences Company Profile and Main Business
        12.8.3 Vtides Life Sciences Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.8.4 Vtides Life Sciences Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.8.5 Vtides Life Sciences Recent Developments
    12.9 Aspen Holdings
        12.9.1 Aspen Holdings Company Information, Head Office, Market Area, and Industry Position
        12.9.2 Aspen Holdings Company Profile and Main Business
        12.9.3 Aspen Holdings Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.9.4 Aspen Holdings Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.9.5 Aspen Holdings Recent Developments
    12.10 Neuland Laboratories
        12.10.1 Neuland Laboratories Company Information, Head Office, Market Area, and Industry Position
        12.10.2 Neuland Laboratories Company Profile and Main Business
        12.10.3 Neuland Laboratories Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.10.4 Neuland Laboratories Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.10.5 Neuland Laboratories Recent Developments
    12.11 USV
        12.11.1 USV Company Information, Head Office, Market Area, and Industry Position
        12.11.2 USV Company Profile and Main Business
        12.11.3 USV Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.11.4 USV Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.11.5 USV Recent Developments
    12.12 Aurigene Pharmaceutical Services
        12.12.1 Aurigene Pharmaceutical Services Company Information, Head Office, Market Area, and Industry Position
        12.12.2 Aurigene Pharmaceutical Services Company Profile and Main Business
        12.12.3 Aurigene Pharmaceutical Services Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.12.4 Aurigene Pharmaceutical Services Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.12.5 Aurigene Pharmaceutical Services Recent Developments
    12.13 CBL
        12.13.1 CBL Company Information, Head Office, Market Area, and Industry Position
        12.13.2 CBL Company Profile and Main Business
        12.13.3 CBL Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.13.4 CBL Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.13.5 CBL Recent Developments
    12.14 Provepharm
        12.14.1 Provepharm Company Information, Head Office, Market Area, and Industry Position
        12.14.2 Provepharm Company Profile and Main Business
        12.14.3 Provepharm Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.14.4 Provepharm Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.14.5 Provepharm Recent Developments
    12.15 PeptiStar
        12.15.1 PeptiStar Company Information, Head Office, Market Area, and Industry Position
        12.15.2 PeptiStar Company Profile and Main Business
        12.15.3 PeptiStar Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.15.4 PeptiStar Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.15.5 PeptiStar Recent Developments
    12.16 Creative Peptides
        12.16.1 Creative Peptides Company Information, Head Office, Market Area, and Industry Position
        12.16.2 Creative Peptides Company Profile and Main Business
        12.16.3 Creative Peptides Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.16.4 Creative Peptides Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.16.5 Creative Peptides Recent Developments
    12.17 Space Peptides
        12.17.1 Space Peptides Company Information, Head Office, Market Area, and Industry Position
        12.17.2 Space Peptides Company Profile and Main Business
        12.17.3 Space Peptides Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.17.4 Space Peptides Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.17.5 Space Peptides Recent Developments
    12.18 Cambrex
        12.18.1 Cambrex Company Information, Head Office, Market Area, and Industry Position
        12.18.2 Cambrex Company Profile and Main Business
        12.18.3 Cambrex Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.18.4 Cambrex Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.18.5 Cambrex Recent Developments
    12.19 ScinoPharm
        12.19.1 ScinoPharm Company Information, Head Office, Market Area, and Industry Position
        12.19.2 ScinoPharm Company Profile and Main Business
        12.19.3 ScinoPharm Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.19.4 ScinoPharm Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.19.5 ScinoPharm Recent Developments
    12.20 Chinese Peptide Company
        12.20.1 Chinese Peptide Company Company Information, Head Office, Market Area, and Industry Position
        12.20.2 Chinese Peptide Company Company Profile and Main Business
        12.20.3 Chinese Peptide Company Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.20.4 Chinese Peptide Company Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.20.5 Chinese Peptide Company Recent Developments
    12.21 ChengDu ShengNuo Biotec
        12.21.1 ChengDu ShengNuo Biotec Company Information, Head Office, Market Area, and Industry Position
        12.21.2 ChengDu ShengNuo Biotec Company Profile and Main Business
        12.21.3 ChengDu ShengNuo Biotec Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.21.4 ChengDu ShengNuo Biotec Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.21.5 ChengDu ShengNuo Biotec Recent Developments
    12.22 WuXi TIDES
        12.22.1 WuXi TIDES Company Information, Head Office, Market Area, and Industry Position
        12.22.2 WuXi TIDES Company Profile and Main Business
        12.22.3 WuXi TIDES Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.22.4 WuXi TIDES Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.22.5 WuXi TIDES Recent Developments
    12.23 Genscript
        12.23.1 Genscript Company Information, Head Office, Market Area, and Industry Position
        12.23.2 Genscript Company Profile and Main Business
        12.23.3 Genscript Peptide Manufacturing and Development Services Models, Specifications, and Application
        12.23.4 Genscript Peptide Manufacturing and Development Services Revenue and Gross Margin, 2020-2025
        12.23.5 Genscript Recent Developments
13 Conclusion
14 Appendix
    14.1 Research Methodology
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Market Estimation Model
    14.4 Disclaimer